Pfizer paid US docs, medical centers $173M in 2012
This article was originally published in Scrip
Pfizer paid US doctors, hospitals and other health care centers more than $173 million last year for clinical research, professional advice, speeches, meals and other expenses.
You may also be interested in...
Using Baxter’s Advate drug as a preventative therapy helped significantly reduce bleeding incidents in a yearlong study.
Mylan CEO Heather Bresch said she is looking to do a sizable deal that helps the US generic and specialty drug maker better compete in a consolidating field of rivals.
Biogen Idec CEO George Scangos is frank about his ambitions to dominate the market for hemophilia therapies, an opportunity he compares to the big biotech’s lead treating multiple sclerosis.